Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease
Abdelrahman Zamzam(St. Michael's Hospital), Mohammad Qadura(St. Michael's Hospital), John Harlock(McMaster University), Muzammil H. Syed(St. Michael's Hospital), John W. Eikelboom(King's College Hospital), Rawand Abdin(McMaster University), Krishna K. Singh(St. Michael's Hospital)
Cited by 26
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
|New England Journal of Medicine|2017|2.4k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k